Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TOMZ reminds me of HGEN ... Rodney Dangerfield plays ...
Selloff on these YoY numbers.. Insane..
Current Business Highlights To Date
Revenues
- Milestone reached in the third quarter of 2020 with total revenues exceeding $21 million in a calendar year.
- Year over year growth in overall revenue through September 30th of $16,882,000 or 376%.
- Year over year growth SteraMist® equipment revenue through September 30th of $13,165,000 or 456%.
- Year over year growth SteraMist® BIT Solution revenue through September 30th of $2,931,000 or 509%.
- Year over year growth in service revenue through September 30th of $786,000 or 76%
Financial Results for the Three Months Ended September 30, 2020 compared to September 30, 2019
? Total net revenue was $4,292,000 compared to $1,600,000, representing an increase of $2,692,000, or 168%.
? SteraMist® equipment-based revenues was $2,945,000 and $669,000, respectively, representing an increase of $2,276,000 or 340%
? SteraMist® BIT Solution-based revenues was $732,000 and $259,000, respectively, representing an increase of $473,000 or 183%
? Service-based revenue was $615,000 and $672,000, respectively, representing a decrease of $57,000 or 8%.
? Domestic revenue was $3,446,000 and $1,288,000, respectively, representing an increase of $2,158,000, or 168%.
? International revenue was approximately $846,000 and $312,000, respectively, representing an increase of $534,000 or 171%.
? Gross margins were 66.1% compared to 71.3%. The lower gross profit is attributable to the product mix in sales.
? Income from operations was $1,096,000, compared to a Loss from operations of ($188,000), representing an increase of $1,284,000.
? Net Income was $1,019,000, or $0.06 on a per share basis compared to a Net loss of ($237,000), or ($0.02) on a per share basis, representing an increase of $1,256,000.
? EBIDTA was $1,274,000 compared to an adjusted net loss of ($5,000). A table reconciling EBITDA to the appropriate GAAP measure is included with the Company's financial information below.
? Cash provided from operations for the nine months ended September 30, 2020 and 2019 of $4,945,000, compared to cash used in operations of ($573,000), respectively.
Balance sheet highlights as of September 30, 2020 and December 31, 2019
? Cash and cash equivalents of approximately $5,885,000 and $897,000, representing an increase of $4,988,000.
? Working capital of $11,692,000 and ($1,266,000), representing an increase of $12,958,000.
? Shareholders’ equity of $13,251,000 and $890,000, representing an increase of $12,361,000.
Current Business Highlights To Date
Revenues
? Milestone reached in the third quarter of 2020 with total revenues exceeding $21 million in a calendar year.
? Year over year growth in overall revenue through September 30th of $16,882,000 or 376%.
? Year over year growth SteraMist® equipment revenue through September 30th of $13,165,000 or 456%.
? Year over year growth SteraMist® BIT Solution revenue through September 30th of $2,931,000 or 509%.
? Year over year growth in service revenue through September 30th of $786,000 or 76%.
Business Highlights
? Increased demand on solution re-orders as disinfecting and decontamination procedures have increased exponentially across the world.
? Saw an increase in Hospital-Healthcare customers purchasing multiple SteraMist units in order to deploy throughout multiple locations and/or areas within a facility.
? Broke ground on installation of permanent fogging system into our Frederick MD Facility.
? Continued development and testing of the “SteraBot” and launch of pilot program at Lithuanian University Hospital.
? Continued development of SteraPack with a tentative launch set for first quarter 2021.
?
Launch of Commercial Division in response to increased demand in Federal Government facilities and agencies, the aircraft (both airplane and helicopter), manufacturing companies, automobile, naval, education, retail, housing and recreation, and of course emergency preparedness for counties and cities.
? SteraMist was featured in a United States Department of Agriculture paper “Cold plasma-activated hydrogen peroxide aerosol on populations of Salmonella Typhimurium and Listeria innocua and quality changes of apple, tomato and cantaloupe during storage – A pilot scale study” is authored by Dr. Xuetong Fan, who has previously contributed to two prior studies regarding direct produce application.
I sure hope so, although I don't know how surprised I will be if they have a good quarter. Hopefully the pps will pleasantly surprise me too.
Some of the recent tweets have been a bit perplexing/untimely to me. This tweet about other companies being investigated for Covid claims doesn't seem necessary, but obviously they think it was important enough to send. Also, on Oct 27th they sent a really nice tweet about preparing schools for the new normal with Steramist. Oct 27th, really??? A tweet like that should have gone out over the summer, when schools were thinking about their plans for starting the school year, not a month or two after.
This is nothing new, and I think many of us agree that their PR work needs a serious upgrading. I'm hoping that they have been so busy with sales that they didn't put out the school tweet earlier. I guess we'll find out soon.
GLTA! TOMZ
I think we will be pleasantly surprised.
Dozens of disinfection companies are under investigation for COVID-19 claims. Check out the latest news: https://t.co/gwGpDch8JL #SteraMist #stopthespread $TOMZ
— SteraMist (@TOMIMist) November 12, 2020
Agree completely gig! G/L <eom>
Yes, you are correct and we have discussed that very point here as to the main reason in the drop of pps, of which we still have not recovered. It does not make sense that this stock price sits where it does based on the previous Q.
With the low float now, this stock has continued to see a steady decline because of the lack on any substantial PR's/interest. This low float should also allow us to move up quickly once we get some positive news. I am looking forward to the Q3 numbers and cc today as well as getting some forward guidance. IMO, this is still a great, growing company to invest in, which is why I have remained here long.
GLTU! TOMZ
gig-- thank you for the correction. Point I was making still stands that the blunder by Shane and perpetuation of that blunder on the message boards built up expectations that did not materialize and as a result the PPS bombed on a pretty darn good quarterly report.
G/L
Tomi did have revenues of $10M in Q2, as reported. People were thinking $15M+ because of Dr. Shane stating that they had over $8M in revenue after 6 weeks into Q2.
I don't want to guess what Q3 will be, however with the recent drop in pps, if we have at least $6-8M in revenues I would expect it not to drop further, and only rise.
GLTU! TOMZ
Expected a little more interest but I hear ya ... TOMZ
19RGS,
Mgt. certainly has been holding their cards close to their chest. As I have said before it does make sense to refill inventory in Q3 + new business. I have made it clear to Harold Paul in emails that shareholders were not happy w/ Shane's misinformation on the Q1 CC. I can't think that they will F... us over again w/ misinformation. They went to the NASDAQ listing which was a lot of work and $ for some reason. Good news is that w/ good stats this afternoon we can trade until 8PM tonight in aftermarket. It could run tonight. Hold on.!!!! 145K covid cases yesterday. This is not going away ie more STERAMIST .
Not even 20,000 in volume, things will look a lot different here after hours and tomorrow imo. This is bottom here imo.
Sure not trading that great right now ... TOMZ
Morning HH/All. I'm hopeful of good numbers as well, but not overly optimistic. It seems that if we were on track to a good quarter, we would have had more PR's (with actual contract $$) other than a quick blurb about working with the PGA and about a bot being used in Lithuania. (I understand there were more but you get my point) It also seems clear to me that emergency government approvals have come easily for many COVID products and services over the last several months, yet we sit here and wait...… Doesn't sound right.
I understand that they are terrible at PR/IR. And perhaps the partners they've been working with were reluctant to give approval for their names in PR....but I would find that odd. Again, maybe it's just their poor ability to effectively communicate with Stockholders and the investing public in general that has caused the lack of positive PR and thus falling SP.
If I am being honest, I am expecting mediocre results for Q3 (sure hope I'm wrong). The only good thing about that is I believe mediocre results are already priced in, and we won't see a massive drop like we did last Q. Of course, in last Q there were "misinterpreted" claims of $10MM in revenue for Q2 from the Co. which were perpetuated on message boards. When it didn't happen, we bombed. So right now we are back where we were after the bomb of Q2, so IMO even mediocre results should keep us here or slightly up instead of the huge selloff we saw in Q2.
Hoping for the best, prepared for the worst.
19
I’m hopeful as well. Don’t be surprised if they file the report at 9:30 AM like prior quarters!
I think they will clearly beat Q2. Looking forward to earnings after hours tomorrow.
Letter from Dr. Shane, tears down nearly every competitor. Is it simply marketing? or a “get to know us” letter for new investors? Or..covering tracks for a poor quarter?
Check out the latest paper by TOMI's CEO, Dr. Halden Shane: "Not all COVID-19 Disinfectants are Created the Same." https://t.co/yH2ExpUVQn #SteraMist #stopthespread $TOMZ pic.twitter.com/JEVbhdFpW1
— SteraMist (@TOMIMist) November 12, 2020
Any guesses on the revenue number?
I’m hopeful for a surprising solution sales number over $2M.
Service maybe accounts for $1.5M, and another $5M of hard product sales.
Very interested to see if they’re actually selling robots and what the international figures equate too. This is my very conservative estimation but wouldn’t be shocked if they come in 1.5x this.
Regardless.. the business is well financed with close to $10M cash, minimal debt and recurring revenue.
Looking for signs of scaling up and additional products ready for sale.
Lets see some upward action here heading into the update ... TOMZ
HH,
Last time around ie Aug, we had a big runup pre earnings release. Very quiet this time around. Seems like no insider buying. As I just said recently, I am glad that we have post market trading this time. 8 PM ET... Lets rock !!!!
Also have some shares of this, I am curious about tomorrow.
Nice buy. i hope we get the justice we deserve ... TOMZ
Added more here, 2,500 at $6.65. This was at $16 ($2) before the last earnings announcement and now is trading at $6.65 ($0.83) where it dropped to after the last call pre split, and now they are one quarter more in to the year. I am expecting awesome numbers and the this is the first call as a Nasdaq stock. Looking for nice upside here in to the rest of the week.
Same. But using a Stop this time around. Fool me once...
hoping for great numbers ... TOMZ
I think we’re still so under the radar that this thing really flys as long as revenue breaks $10M. I’ve ran some rough numbers and think they should be pulling at least $2M from solution sales and $2M from training alone. Who knows how busy they’ve really been with with manufacturers up and running. Who knows if they’ve sold robots!
KAIROS,
TOO QUIET HERE !!!!!!!!. At least we hae after market trading after the conf. call. We did not have that option in May . Time to pray for BIG sales and profit numbers !!
Pfizer’s vaccine is being developed in their new Chesterfield, MO location. Tomi has 20 ceiling mounted disinfection units in the facility in 4 different clean rooms. How’s that for a stamp of approval for the Gold Standard of disinfection.
Our services have been inundated yet again this past week. The team have travelled across the UK with businesses including office premises, car showrooms and even a truck needing our specialist decontamination skills. #decontamination #COVIDー19 #deepclean pic.twitter.com/AWCZ3V7IqB
— Bio Decontamination Ltd (@Bio_DeconUK) November 9, 2020
5$ adds lookin' pretty good right now ... TOMZ
Pfizer news comes from a trial of 94 in which half of them got a placebo. “Even if all goes well it will be will into 2021 before more Americans can get a vaccine, experts say.”
Buy this dip.
earning 4:30 thurs! expect the numbers and growth to be pretty impressive!
i was a buyer also ... lol
wow- loaded bunch 5.80 people are nutz!!!!
Covid vaccine news hurting TOMZ ... still going to need this product ... TOMZ
gapping down. I will take some cheapies today ... TOMZ
j93,
I ask Harold when would the earnings would be released and the time and date for Shane's earnings CC. I have been in communication with Harold Paul since Feb/ March. Harold is not the most diplomatic of IR people. It is great that we are NASDAQ but I am ready to ring the cash register. If the Q3 earnings/sales are up like $25 million for the Q3 then off to the races.
Hey HH...what did you ask him specifically? Thanks!
HH,
Email from Harold .
Not out yet. The Q will be filed on time, the earnings release a few days before and the call after the Q is filed.
Harold Paul
General Counsel
They were already debt free and now are adding $50 million to the coffers for expansion. The offering size is almost 50% of their current market cap, it goes to show you how big they are going to be and the interest because of the size.
This will be going from a $100m company to a $1b company in 2021. I think we will be pleasantly surprised come earnings announcement in a few days.
I smell a dividend down the road too.
$50M Shelf Offering field today
Thanks for the reminder. If numbers are good we will see some new blood here. Patience.
8 days to earnings after hours 11/16, this will be over $12 by close 11/17 imo.
bid/ask was tighter a few minutes ago until the ask was taken out. notice more bids spaced close together on L2 ... TOMZ
i looked but dont see thick and tight...remember bid ask posturing is momentary and often meant to confuse...looks maybe like another complacency nudge...?
Followers
|
77
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
4770
|
Created
|
09/09/08
|
Type
|
Free
|
Moderators |
BEVERLY HILLS, Calif., March 02, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (OTCQB:TOMZ), is a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products - a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP). In the continuing effort to combat coronavirus (COVID-19) both overseas and domestically, SteraMist has officially been declared the official decontamination technology of the Seoul City Metro Transit in South Korea.
South Korea’s national total of COVID-19 cases has grown to over 4,000 according the South Korean Centers for Disease Control and Prevention (KCDC). Detecting the early stages of COVID-19 infection can prove to be difficult, and direct contact with the virus that are on common surfaces such as railings, vending machines and train seats in rapid transit systems worldwide are thought to be a mechanism for transference.
An established five-year TOMI authorized distributor in South Korea, GD Sciences, has begun to address this problem by utilizing SteraMist technology in transit systems, focusing primarily on the metropolitan transit system of South Korea’s capital city, Seoul. The annual ridership of the Seoul Metropolitan Subway is over 1.2 billion. This application has allowed SteraMist to become a critical line of defense as a preventative measure against the rapid spread of COVID-19.
Joseph So, the CEO of GD Sciences, states, “We experienced a similar outbreak with MERS years ago and have dealt with these types of infectious disease outbreaks in the past. The number of confirmed patients is higher than five years ago, but rest assured that Seoul’s Metro System is in safe hands with the use of SteraMist decontamination equipment and its rapid ease of application with six-log (99.9999%) efficacy.”
On-site application of SteraMist has been tested throughout transportation venues in the metro subway trains, treating surfaces such as seating, handles, vending machines, walls, floors, and doors. Joining the workers treating the area with SteraMist was Seoul’s mayor, Park Won-soon. Seeing the success of SteraMist disinfection, the mayor has hired GD Science to service the Seoul Metropolitan Rapid Transit Corporation (SMRT).
TOMI’s CEO, Dr. Halden Shane, states, “We are pleased to announce this opportunity to help protect the city of Seoul and fight the ongoing threat of COVID-19 by ensuring a healthier transit environment through SteraMist. Just as new cases of infection are continuously growing in countries around the world, this is yet another step in our commitment to global cooperation as we continue to innovate for a safer world in the face of new and existing pathogen threats.”
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
Already EPA-registered on lists J, K, G, and L, which include H1N1 or Influenza A (enveloped) and Norovirus (non-enveloped), TOMI anticipates to secure listing in the EPA’s upcoming publication of Emerging Pathogen Lists, which includes COVID-19. SteraMist was also featured as the only disinfectant product in the World Health Organization Compendium of Innovative Health Technologies.
SteraMist is now the industry standard throughout China after TOMI recently received approval and registration for two (2) separate registrations - SteraMist equipment registration and BIT solution registration - from the Chinese Center for Disease Control and Prevention (China CDC). With the latest outbreak, China is able to take advantage of SteraMist disinfection and its ability to rapidly deploy throughout the country as needed. TOMI is finalizing negotiations with high-level Chinese officials for use of the SteraMist Surface Unit in aiding the control of COVID-19.
______________________________________________________
*** Breaking News**** 2/5/2020
A YORK company is waiting to decontaminate the infected city hotel room where the only two confirmed coronavirus patients in the UK had been staying.
Bio Decon Group is waiting for the all-clear from Public Health England to begin its work at the StayCity hotel, next to York Barbican.
Andy McMillan, managing director of Bio Decon Group, said his company is the only one in the UK that can tackle the job. He said: “This is massive for York as we are the only company with the TOMI Steramist licence in the UK that can eradicate this virus.
“We are now waiting for Public Health England to release the room and corridor back to StayCity York and we will carry out the decontamination process.
“It’s important that we act quickly and help York as a city.
“We are on high alert and in constant contact with Public Health England in case any more cases occur.”
TOMI Steramist Environmental Solutions is working in Asia to help disinfect areas that have become contaminated.
StayCity York said that a date to begin decontaminating the room is still not confirmed, and the room remains cordoned off.
The York pair who contracted the virus - one of whom is a University of York student - were first seen by health officials on Wednesday last week.
On Friday, it was confirmed that the pair had become the first to test positive for the coronavirus in the UK.
--------------------------------------------------------------------------
***Breaking News*** 2/4/2020
BEVERLY HILLS, Calif., Feb. 04, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (OTCQB: TOMZ), is a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products - a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP). Effective immediately, SteraMist equipment and BIT solution has been registered with the Chinese Center for Disease Control and Prevention (China CDC).
After a three (3) year-long submission process, TOMI recently received confirmation that two (2) separate registrations - SteraMist equipment registration and BIT solution registration - have now been officially approved and registered with the China CDC.
SteraMist is now the industry standard for disinfection throughout all of China. This registration allows China to take advantage of SteraMist disinfection and decontamination in a variety of verticals such as healthcare, pharmaceutical, commercial and residential, schools, and throughout the community.
With the latest outbreak of coronavirus 2019-nCoV, TOMI is able to rapidly deploy SteraMist throughout the country as needed and requested. China’s registration adds to the long list of countries in which TOMI is registered and utilized.
TOMI’s CEO, Dr. Halden Shane, states “TOMI is excited to announced that we are now registered with the China CDC. Throughout the world, SteraMist is used to eradicate enveloped viruses, similar to coronavirus, and is the superior disinfection for use in spaces such as transportation avenues, hospitals, and other emergency areas. After a long registration process, SteraMist is the industry standard and future of disinfection and decontamination throughout China, which is a substantial milestone for our company.”
--------------------------------------------------------
** Breaking twitter News "See our recently released update to stay informed about coronavirus and find out how you can prevent infection: https://tomimist.com/wp-content/uploads/2020/01/Coronavirus-Update.pdf… #SteraMist #coronavirus
---------------------------------------------------------------------
** Breaking News Update 1/29/2020
TOMI’s SteraMist Preparedness for Aiding in the new Coronavirus-Wuhan or 2019-nCoV Outbreak
With thousands of confirmed cases of the respiratory infection already noted worldwide, health officials have confirmed at least five (5) cases of coronavirus-Wuhan (2019-nCoV) in the United States. This virus could become our next pandemic.
Similar to Influenza A, SARS, and MERS, coronavirus is an enveloped virus. While this would often serve to protect the virus from possible threats, SteraMist features efficacy against Influenza A, SARS, MERS and similar, enveloped viral threats including coronavirus-Wuhan (2019-nCoV). TOMI has multiple EPA-accepted studies on the current label to meet the standard to respond to emerging pathogens in the enveloped and non-enveloped categories, which includes the current coronavirus-Wuhan (2019-nCoV) outbreak.
TOMI Environmental Solutions has partners throughout the globe standing by to rapidly deploy and aid in reducing the spread of this coronavirus-Wuhan (2019-nCoV) using SteraMist disinfection and decontamination. Companies in biological disaster management and emerging disease organizations throughout the world make up a strong, growing list of TOMI premier partners.
TOMI CEO, Dr. Halden Shane, states that “SteraMist has proven success against emerging pathogens and we remain confident in the ability of our technology to reduce the viral duplication in the air and on surfaces of all indoor environments in the fight against this novel coronavirus-Wuhan (2019-nCoV) threat. TOMI is working alongside many of our premier partners throughout Asia and, if needed, the world to bring SteraMist to those in need of the most effective disinfectant and decontaminant to fight coronavirus-Wuhan (2019-nCoV).”
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (OTCQB:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.
TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.
TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.
For additional information, please visit http://www.tomimist.com/ or contact us at info@tomimist.com.
TOMI Environmental Solutions, Inc.
TOMI Environmental Solutions, Inc. is a global bacteria decontamination and infectious disease control company, providing environmental solutions for indoor surface decontamination through the manufacturing, sales and licensing of its SteraMist brand products. SteraMist is an EPA registered sole active ingredient Hydrogen Peroxide based product line that uses Binary Ionization Technology (BIT). Check out the ionized Hydrogen Peroxide (iHP) process here.
TOMI received its first EPA hospital-healthcare general disinfectant label in 2015, in what is regarded as a heavily regulated and very competitive industry. In 2016, TOMI amended the label to include C.difficle spores and h1n1. In 2017, the EPA approved additional registrations of Salmonella and Norovirus to the TOMI label. Further, Binary Ionization Technology (BIT) can be found on EPA Lists K, L, G, and M. TOMI continues to advance its research & development efforts, while protecting current and securing future intellectual property. In addition to a long list, TOMI consistently pursues international product registrations.
The four primary divisions of TOMI include: Hospital-Healthcare , Life Sciences, TOMI Service Network (TSN), and Food Safety. TOMI offers a variety of products and services to fulfill the disinfection needs of those industries. SteraMist Surface Unit is a fully portable, hand-held, point and spray disinfection and decontamination unit. SteraMist Environment System is a complete room decontamination fogging system. In all of its divisions, TOMI remains committed to a focus on both customer satisfaction and client retention.
TOMI has extensive experience in developing training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, and The Restoration Industry Association.
TOMI recognizes there is an immediate global need to share its state of the art technology with all communities throughout the world. Dr. Halden Shane, CEO, has stated, “The entire team at TOMI is committed to combating public health threats while constantly working to realize our mission of Innovating for a Safer World.”
TOMI Environmental Solutions is committed to creating a healthier world through use of our globally registered platform of SteraMist products. Demonstrating core values of results, teamwork, inspired products and customer satisfaction, TOMI strives to innovate for a safer world in healthcare, food safety, life sciences and through the TOMI Service Network.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |